Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-17

Clinical Trial Update: Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating etanercept (Enbrel) for moderate rheumatoid arthritis, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-06-17